SWA
NKTR icon

Sutton Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History

Sutton Wealth Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13
Closed -$602 – 1692
2022
Q3 		$602 Buy
+13
New +$773 ﹤0.01% 1435
2022
Q2 		– Sell
-210
Closed -$17K – 1688
2022
Q1 		$17K Buy
210
+170
+425% +$25.2K 0.01% 764
2021
Q4 		$8.2K Buy
40
+3
+8% +$651 ﹤0.01% 996
2021
Q3 		$10.1K Hold
37
– – ﹤0.01% 905
2021
Q2 		$9.63K Hold
37
– – ﹤0.01% 922
2021
Q1 		$11.2K Hold
37
– – ﹤0.01% 841
2020
Q4 		$9.54K Hold
37
– – ﹤0.01% 822
2020
Q3 		$9.31K Hold
37
– – ﹤0.01% 761
2020
Q2 		$13K Hold
37
– – 0.01% 640
2020
Q1 		$10K Buy
+37
New +$11.4K 0.01% 652
2019
Q3 		– Sell
-1
Closed -$367 – 1201
2019
Q2 		$427 Sell
1
-1
-50% -$501 ﹤0.01% 1142
2019
Q1 		$1.01K Hold
2
– – ﹤0.01% 1110
2018
Q4 		$986 Sell
2
-8
-80% -$4.83K ﹤0.01% 1040
2018
Q3 		$8.78K Sell
10
-18
-64% -$15.4K 0.01% 812
2018
Q2 		$20.2K Buy
28
+12
+75% +$13.8K 0.01% 587
2018
Q1 		$25.6K Sell
16
-138
-90% -$178K 0.02% 473
2017
Q4 		$138K Buy
154
+28
+22% +$16.6K 0.1% 165
2017
Q3 		$45.4K Sell
126
-14
-10% -$4.38K 0.03% 293
2017
Q2 		$41.1K Buy
140
+2
+1% +$578 0.03% 299
2017
Q1 		$48.5K Buy
138
+34
+33% +$7.64K 0.04% 269
2016
Q4 		$19.1K Hold
104
– – 0.02% 513
2016
Q3 		$26.8K Hold
104
– – 0.02% 386
2016
Q2 		$22.2K Hold
104
– – 0.02% 420
2016
Q1 		$21.4K Buy
+104
New +$20K 0.02% 419

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sutton Wealth Advisors's NKTR Position: Q4 2022 in Review

Sutton Wealth Advisors sold out of Nektar Therapeutics (NKTR) in Q4 2022, closing a stake of 13 shares — an estimated $602 sold.

Sutton Wealth Advisors first reported a position in NKTR in Q1 2016 and held it in 24 quarters. The position peaked at $138K in Q4 2017. 214 funds tracked by Wall St. Rank hold NKTR as of Q4 2022.

  • Sutton Wealth Advisors reported no remaining Nektar Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Sutton Wealth Advisors sold 13 Nektar Therapeutics shares in Q4 2022, an estimated $602.
  • Sutton Wealth Advisors first reported a position in Nektar Therapeutics in Q1 2016 and held it in 24 quarters.
  • Sutton Wealth Advisors's Nektar Therapeutics position peaked at $138K in Q4 2017.
  • 214 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2022.

Based on Sutton Wealth Advisors's 13F filing for Q4 2022, filed 7 Nov 2023.